PUBLICACIÓN
Losartan hydroxylation phenotype in an Ecuadorian population: Influence of CYP2C9 genetic polymorphism, habits and gender
Dorado P., Beltran L.J., MacHin E., Penas-Lledo E.M., Teran E., Llerena A.
2012 PHARMACOGENOMICS
Genetics (Q3), Molecular Medicine (Q2), Pharmacology (Q2)
JCR: 3.857
SJR: 0.968
CITAS
28
DOI
10.2217/pgs.12.160
EID
2-s2.0-84870042059
ISSN
1462-2416
EISSN
1744-8042
BIBTEX
@article{Dorado2012,title = {Losartan hydroxylation phenotype in an Ecuadorian population: Influence of CYP2C9 genetic polymorphism, habits and gender},journal = {Pharmacogenomics},year = {2012},volume = {13},number = {15},pages = {1711-1717},author = {Dorado, P. and Beltr{\'a}n, L.J. and MacH{\'i}n, E. and Pe{\~n}as-Lled{\'o}, E.M. and Ter{\'a}n, E. and Llerena, A.}}
AUTORES DE LA UEX